Murray Esler Selected Research

Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)

5/2012	The human sympathetic nervous system: its relevance in hypertension and heart failure.
2/2010	The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.
5/2005	Sympathetic neuronal regulation of the heart in aging and heart failure.
7/2003	Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Murray Esler Research Topics

Disease

32	Hypertension (High Blood Pressure) 01/2020 - 09/2005
13	Essential Hypertension 01/2022 - 06/2002
13	Heart Failure 01/2022 - 11/2002
9	Panic Disorder (Panic Attack) 01/2022 - 06/2004
6	Obesity 04/2010 - 05/2004
4	Weight Loss (Weight Reduction) 11/2017 - 02/2003
4	Overweight 11/2017 - 09/2005
4	Postural Orthostatic Tachycardia Syndrome 03/2017 - 06/2008
3	Tachycardia (Tachyarrhythmias) 01/2020 - 11/2002
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2007 - 01/2006
2	Orthostatic Hypotension (Postural Hypotension) 08/2004 - 11/2002
2	Pure Autonomic Failure 05/2003 - 11/2002
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Erectile Dysfunction 01/2022
1	Peripheral Arterial Disease 01/2022
1	Myocardial Stunning (Stunned Myocardium) 01/2022
1	Takotsubo Cardiomyopathy 01/2022
1	COVID-19 01/2020
1	Isolated Systolic Hypertension 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Pheochromocytoma 04/2016
1	Chronic Renal Insufficiency 03/2016
1	Fibrosis (Cirrhosis) 05/2015
1	Renal Insufficiency (Renal Failure) 07/2014
1	Metabolic Diseases (Metabolic Disease) 07/2014
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2013
1	Hypercholesterolemia 02/2013
1	Dyslipidemias (Dyslipidemia) 02/2013
1	Hyperemia 02/2013
1	Major Depressive Disorder (Major Depressive Disorders) 01/2013
1	Hypotension (Low Blood Pressure) 10/2011
1	Insulin Resistance 05/2011
1	Hypertension Resistant to Conventional Therapy 02/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2006
1	Depressive Disorder (Melancholia) 06/2005
1	Coronary Vasospasm (Coronary Artery Vasospasm) 06/2004
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2004
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2003

Drug/Important Bio-Agent (IBA)

15	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 06/2002
9	Antihypertensive Agents (Antihypertensives)IBA 04/2016 - 09/2005
6	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022 - 05/2003
6	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 03/2017 - 07/2006
6	Pharmaceutical PreparationsIBA 01/2017 - 08/2004
4	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 06/2004
4	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 05/2012 - 07/2003
4	LeptinIBA 07/2007 - 05/2003
3	Adrenergic Agents (Adrenergic Drugs)IBA 12/2020 - 05/2007
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2008
3	IsotopesIBA 01/2020 - 06/2002
3	Biological ProductsIBA 12/2008 - 01/2006
3	Vasoconstrictor AgentsIBA 04/2008 - 02/2006
3	Neurotransmitter Agents (Neurotransmitter)IBA 08/2007 - 11/2002
3	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2005 - 11/2002
2	CatecholaminesIBA 01/2022 - 06/2004
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020 - 04/2006
2	SympatholyticsIBA 11/2017 - 08/2004
2	moxonidine (Moxon)IBA 11/2017 - 05/2012
2	DiureticsIBA 09/2012 - 04/2009
2	Rilmenidine (Hyperium)IBA 05/2012 - 08/2004
2	eprosartan (Teveten)FDA Link 04/2006 - 06/2002
2	Losartan (Cozaar)FDA LinkGeneric 04/2006 - 06/2002
2	Neuropeptide YIBA 06/2004 - 07/2003
1	Indicators and Reagents (Reagents)IBA 01/2022
1	CH 66IBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2015
1	SodiumIBA 07/2013
1	C-Reactive ProteinIBA 02/2013
1	LipidsIBA 02/2013
1	HDL LipoproteinsIBA 02/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2013
1	CholesterolIBA 02/2013
1	ReninIBA 09/2012
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 08/2012
1	Vasopeptidase InhibitorsIBA 08/2012
1	ImidazolinesIBA 05/2012
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2011
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 07/2011
1	GhrelinIBA 07/2011
1	C-PeptideIBA 05/2011
1	Insulin (Novolin)FDA Link 05/2011
1	Glucose (Dextrose)FDA LinkGeneric 05/2011
1	Hemoglobin AIBA 05/2011
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2007
1	Citalopram FDA LinkGeneric 08/2007
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2007
1	ChromatinIBA 07/2006
1	Transcription Factors (Transcription Factor)IBA 07/2006
1	DNA (Deoxyribonucleic Acid)IBA 07/2006
1	Angiotensin Receptor AntagonistsIBA 04/2006
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2004
1	Carvedilol (Coreg)FDA LinkGeneric 07/2003
1	SteroidsIBA 11/2002

Therapy/Procedure

21	Denervation 01/2019 - 04/2009
14	Catheters 01/2017 - 04/2009
12	Therapeutics 01/2022 - 07/2003
9	Sympathectomy (Sympathectomies) 07/2014 - 11/2002
2	Caloric Restriction 11/2017 - 02/2003
1	Transcatheter Aortic Valve Replacement 11/2013
1	Aftercare (After-Treatment) 05/2011